天风·医药 | 小核酸药物行业专题: 曲径通幽,星辰大海逐浪高

天风研究
Oct 09

我们系统梳理了小核酸药物在心血管/慢病、慢乙肝、罕见病、肿瘤的临床进展和试验结果,也将海外及国内小核酸药物代表企业及管线做了详细呈现。整体而言,我们认为小核酸是继小分子、抗体药物后的另一大药物类型,凭借研发及商业化的不断突破,有望迎来新一轮高速发展期。投资策略:小核酸药物主要通过与细胞内的mRNA发生碱基互补配对作用,从转录后水平调节蛋白质的表达,以实现治疗疾病的目的。行业历经基础研究阶段(...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10